BioClinica rolls out tech-enabled postapproval research service

BioClinica has added a postapproval research unit to its service offerings. The division, which the company has set up to meet rising demand for postapproval research, will make use of BioClinica's technology capabilities. Specifically, BioClinica has applied its skills to the creation of a postapproval technology platform, which is designed to simplify the research process while providing access to study metrics. Release

Suggested Articles

The new solution aims to streamline the incorporation of human genomic data into clinical trial designs.

TriNetX's platform uses EHR data to help drug developers with clinical trial protocol design and study site and participant identification.

The $58 million financing round represents biopharma industry's growing interest in genomics data.